UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 616.

A

Abi-Rached, L; Jobin, MJ; Kulkarni, S; McWhinnie, A; Dalva, K; Gragert, L; Babrzadeh, F; (2011) The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans. SCIENCE , 334 (6052) pp. 89-94. 10.1126/science.1209202.

Agostinelli, C; Hartmann, S; Klapper, W; Korkolopoulou, P; Righi, S; Marafioti, T; Piccaluga, PP; (2011) Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive. HISTOPATHOLOGY , 59 (4) pp. 679-691. 10.1111/j.1365-2559.2011.03981.x.

Aguilera, R; Saffie, C; Tittarelli, A; Gonzalez, FE; Ramirez, M; Reyes, D; Pereda, C; (2011) Heat-Shock Induction of Tumor-Derived Danger Signals Mediates Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells. CLIN CANCER RES , 17 (8) 2474 - 2483. 10.1158/1078-0432.CCR-10-2384.

Aitchison, KL; Rahim, AA; Hughes, DA; Kinnon, C; Waddington, SN; Howe, SJ; (2011) Lentiviral vectors for gene therapy of Type I Gaucher Disease. HUM GENE THER , 22 (10) A44 - A44.

Akers, NK; Curry, JD; Conde, L; Bracci, PM; Smith, MT; Skibola, CF; (2011) Association of HLA-DQB1 alleles with risk of follicular lymphoma. Leuk Lymphoma , 52 (1) pp. 53-58. 10.3109/10428194.2010.532888.

Albanyan, AA; Albanyan, A; Curry, B; Dragovic, R; Gardiner, C; Biggerstaff, J; Murphy, M; (2011) Measurement of procoagulant microvesicles generated within ageing platelet concentrates. In: (pp. pp. 62-63).

Aleman, MM; Gardiner, C; Harrison, P; Wolberg, AS; (2011) Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. Journal of Thrombosis and Haemostasis , 9 (11) pp. 2251-2261. 10.1111/j.1538-7836.2011.04488.x. Green open access
file

Allay, JA; Sleep, S; Long, S; Tillman, DM; Clark, R; Carney, G; Fagone, P; (2011) Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial. HUM GENE THER , 22 (5) 595 - 604. 10.1089/hum.2010.202.

Allen, CG; Hills, RK; Evans, CM; Lamb, K; Sellar, R; Moorman, AV; Sale, M; (2011) Mutations in a Large Cohort of Young Adult Patients with Core Binding Factor Acute Myeloid Leukemia: Impact on Outcome and the Selection of Patients for Alternative Treatment Including Transplantation in First Complete Remission. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 193). AMER SOC HEMATOLOGY

Alvarez-Erviti, L; Seow, Y; Schapira, AH; Gardiner, C; Sargent, IL; Wood, MJA; Cooper, JM; (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiology of Disease , 42 (3) 360 - 367. 10.1016/j.nbd.2011.01.029. Green open access
file

Amary, MF; Bacsi, K; Maggiani, F; Damato, S; Halai, D; Berisha, F; Pollock, R; (2011) IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J PATHOL , 224 (3) 334 - 343. 10.1002/path.2913.

Amary, MF; Damato, S; Halai, D; Eskandarpour, M; Berisha, F; Bonar, F; McCarthy, S; (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet , 43 (12) pp. 1262-1265. 10.1038/ng.994.

Anderson, K; Lutz, C; van Delft, FW; Bateman, CM; Guo, Y; Colman, SM; Kempski, H; (2011) Genetic variegation of clonal architecture and propagating cells in leukaemia. NATURE , 469 (7330) 356-+. 10.1038/nature09650.

Andrady, C; Sharma, SK; Chester, KA; (2011) Antibody-enzyme fusion proteins for cancer therapy. IMMUNOTHERAPY-UK , 3 (2) 193 - 211. 10.2217/IMT.10.90.

Anoop, P; Shaw, BE; Riley, U; Ethell, ME; Taj, M; Lancaster, DL; Atra, A; (2011) Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. HEMATOLOGY , 16 (4) 213 - 220. 10.1179/102453311X13025568941763.

Arce, F; Breckpot, K; Collins, M; Escors, D; (2011) Targeting lentiviral vectors for cancer immunotherapy. Curr Cancer Ther Rev , 7 (4) pp. 248-260. 10.2174/157339411797642605. Green open access
file

Arce, F; Breckpot, K; Stephenson, H; Karwacz, K; Ehrenstein, MR; Collins, M; Escors, D; (2011) Selective ERK Activation Differentiates Mouse and Human Tolerogenic Dendritic Cells, Expands Antigen-Specific Regulatory T Cells, and Suppresses Experimental Inflammatory Arthritis. ARTHRITIS RHEUM-US , 63 (1) 84 - 95. 10.1002/art.30099.

Arkenau, H-K; (2011) Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy? Ann Oncol , 22 (1) pp. 239-240. 10.1093/annonc/mdq676.

Arkenau, H-T; Kefford, R; Long, GV; (2011) Targeting BRAF for patients with melanoma. Br J Cancer , 104 (3) pp. 392-398. 10.1038/sj.bjc.6606030.

Arkenau, H-T; Nordman, I; Dobbins, T; Ward, R; (2011) Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer. Cancer , 117 (4) pp. 832-840. 10.1002/cncr.25636.

Arrieta Bolanos, ER; Maldonado-Torres, H; Dimitriu, O; Hoddinott, MA; Fowles, F; Shah, A; Órlich-Pérez, P; (2011) HLA-A, -B, -C, -DQB1, and -DRB1,3,4,5 allele and haplotype frequencies in the Costa Rica Central Valley Population and its relationship to worldwide populations. Human Immunology , 72 (1) pp. 80-86. 10.1016/j.humimm.2010.10.005.

Arteche, A; Joormann, J; Harvey, A; Craske, M; Gotlib, IH; Lehtonen, A; Counsell, N; (2011) The effects of postnatal maternal depression and anxiety on the processing of infant faces. J Affect Disord , 133 (1-2) pp. 197-203. 10.1016/j.jad.2011.04.015.

Arthold, S; Kurowski, A; Wutz, A; (2011) Mechanistic insights into chromosome-wide silencing in X inactivation. Hum Genet , 130 (2) pp. 295-305. 10.1007/s00439-011-1002-0.

Averbuch, D; Chapgier, A; Boisson-Dupuis, S; Casanova, J-L; Engelhard, D; (2011) The clinical spectrum of patients with deficiency of Signal Transducer and Activator of Transcription-1. Pediatr Infect Dis J , 30 (4) pp. 352-355. 10.1097/INF.0b013e3181fdff4a.

Ayto, RM; Reed, M; Baker, R; Steele, AJ; Wickremasinghe, RG; Mehta, AB; Hughes, DA; (2011) Gaucher derived mono-layers prime myeloma cells for survival against chemo-therapeutic agents. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 16). WILEY-BLACKWELL

B

Babu, B; Lee, M; Lee, L; Strobel, R; Brockway, O; Nickols, A; Sjoholm, R; (2011) Acetyl analogs of combretastatin A-4: Synthesis and biological studies. BIOORGAN MED CHEM , 19 (7) 2359 - 2367. 10.1016/j.bmc.2011.02.018.

Babu, B; Liu, Y; Plaunt, A; Riddering, C; Ogilvie, R; Westrate, L; Davis, R; (2011) Design, synthesis and DNA binding properties of orthogonally positioned diamino containing polyamide f-IPI. BIOCHEM BIOPH RES CO , 404 (3) 848 - 852. 10.1016/j.bbrc.2010.12.073.

Babu, B; Ramos, J; Liu, Y; Chavda, S; Tzou, S; Brockway, O; Sjoholm, R; (2011) Design, synthesis, and DNA binding selectivity and affinity studies of the tetraamide PhIPI and its diamino analog PhIP*I. In: (Proceedings) 242nd National Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Baird, RD; Venugopal, B; Kristeleit, RS; Charlton, J; Blanco-Codesido, M; Saunders, E; Shah, KJ; (2011) A first-in-human phase I study of JNJ-26481585, a novel oral histone deacetylase inhibitor (HDACi), in patients with advanced cancer with evidence of target modulation and antitumor activity. JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

Ball, J; Cohen, H; Knowles, S; (2011) A retrospective audit of fluid balance recording in transfusion associated circulatory overload (TACO) reports analysed by the serious hazards of transfusion 9SHOT) scheme. In: (Proceedings) British Blood Transfusion Society.

Ballingall, KT; Herrmann-Hoesing, L; Robinson, J; Marsh, SGE; Stear, MJ; (2011) A single nomenclature and associated database for alleles at the major histocompatibility complex class II DRB1 locus of sheep. TISSUE ANTIGENS , 77 (6) pp. 546-553. 10.1111/j.1399-0039.2011.01637.x.

Banks, MR; Haidry, R; Butt, MA; Whitley, L; Stein, J; Langmead, L; Bloom, SL; (2011) High resolution colonoscopy in a bowel cancer screening program improves polyp detection. WORLD JOURNAL OF GASTROENTEROLOGY , 17 (38) pp. 4308-4313. 10.3748/wjg.v17.i38.4308. Gold open access

Baraniskin, A; Munding, J; Schulmann, K; Meier, D; Porschen, R; Arkenau, H-T; Graeven, U; (2011) Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group. Clin Colorectal Cancer , 10 (1) pp. 24-29. 10.3816/CCC.2011.n.003.

Barton, S; Swanton, C; (2011) Recent developments in treatment stratification for metastatic breast cancer. Drugs , 71 (16) pp. 2099-2113. 10.2165/11594480-000000000-00000.

Bateman, A; Agrawal, S; Birney, E; Bruford, EA; Bujnicki, JM; Cochrane, G; Cole, JR; (2011) RNAcentral: A vision for an international database of RNA sequences. RNA , 17 (11) pp. 1941-1946. 10.1261/rna.2750811.

Bates, AW; (2011) The anatomy of beauty in nineteenth-century England. Hektoen International , 3 (1)

Bell, CG; (2011) Accessing and selecting genetic markers from available resources. Methods Mol Biol , 760 pp. 1-17. 10.1007/978-1-61779-176-5_1.

Bell, CG; (2011) Integration of genomic and epigenomic DNA methylation data in common complex diseases by haplotype-specific methylation analysis. PERS MED , 8 (3) 243 - 251. 10.2217/PME.11.14.

Beltran, L; Chaussade, C; Vanhaesebroeck, B; Cutillas, PR; (2011) Calpain interacts with class IA phosphoinositide 3-kinases regulating their stability and signaling activity. Proc Natl Acad Sci U S A , 108 (39) pp. 16217-16222. 10.1073/pnas.1107692108.

Bennett, CL; Fallah-Arani, F; Conlan, T; Trouillet, C; Goold, H; Chorro, L; Flutter, B; (2011) Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin. Blood , 117 (26) 7063 - 7069. 10.1182/blood-2011-01-329185.

Bennett, K; James, C; Mutair, A; Al-Shaikh, H; Sinani, A; Hussain, K; (2011) Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene. PEDIATRIC DIABETES , 12 (3) pp. 192-196. 10.1111/j.1399-5448.2010.00683.x.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; Buckley, S; (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45 - A45.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; Buckley, S; (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45-A45.

Birkbak, NJ; Eklund, AC; Li, Q; McClelland, SE; Endesfelder, D; Tan, P; Tan, IB; (2011) Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res , 71 (10) pp. 3447-3452. 10.1158/0008-5472.CAN-10-3667.

Bjedov, I; Partridge, L; (2011) A longer and healthier life with TOR down-regulation: genetics and drugs. In: BIOCHEMICAL SOCIETY TRANSACTIONS. (pp. 460 - 465). PORTLAND PRESS LTD

Blanc, V; Nariculam, J; Munson, P; Freeman, A; Klocker, H; Masters, J; Williamson, M; (2011) A Role for Class 3 Semaphorins in Prostate Cancer. PROSTATE , 71 (6) pp. 649-658. 10.1002/pros.21281.

Bochtler, W; Maiers, M; Bakker, JNA; Oudshoorn, M; Marsh, SGE; Baier, D; Hurley, CK; (2011) World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplant , 46 pp. 338-343.

Bolli, N; Payne, EM; Rhodes, J; Gjini, E; Johnston, AB; Guo, F; Lee, J-S; (2011) cpsf1 is required for definitive HSC survival in zebrafish. Blood , 117 (15) pp. 3996-4007. 10.1182/blood-2010-08-304030.

Boo, M; van Walraven, SM; Chapman, J; Lindberg, B; Schmidt, AH; Shaw, BE; Switzer, GE; (2011) Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. BLOOD , 117 (1) 21 - 25. 10.1182/blood-2010-07-298430.

Boshoff, C; (2011) Unraveling virus-induced lymphomagenesis. J CLIN INVEST , 121 (3) 838 - 841. 10.1172/JCI46499. Gold open access

Bouma, G; Mendoza-Naranjo, A; Blundell, MP; de Falco, E; Parsley, KL; Burns, SO; Thrasher, AJ; (2011) Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming. BLOOD , 118 (9) 2492 - 2501. 10.1182/blood-2011-03-340265.

Bramham, K; Hilton, R; Horsfield, C; McDonald, V; Camilleri, R; Hunt, BJ; (2011) ADAMTS-13 deficiency: can it cause chronic renal failure? Nephrol Dial Transplant , 26 (2) pp. 742-744. 10.1093/ndt/gfq644.

Bramham, K; Hilton, R; Horsfield, C; McDonald, V; Camilleri, R; Hunt, BJ; (2011) ADAMTS-13 deficiency: can it cause chronic renal failure? NEPHROL DIAL TRANSPL , 26 (2) 742 - 744. 10.1093/ndt/gfq644.

Bravo, R; Vicencio, JM; Parra, V; Troncoso, R; Munoz, JP; Bui, M; Quiroga, C; (2011) Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J CELL SCI , 124 (13) 2143 - 2152. 10.1242/jcs.080762.

Bravo, R; Vicencio, JM; Parra, V; Troncoso, R; Munoz, JP; Bui, M; Quiroga, C; (2011) Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress (vol 124, pg 2143, 2011). J CELL SCI , 124 (14) 2511 - 2511. 10.1242/jcs.095455.

Bridgewater, JA; Stubbs, C; Primrose, JN; National Cancer Research Institute (UK) Upper Gastrointestinal S, ; (2011) BILCAP: A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer. J Clin Oncol , 29 (15_suppl) 4125-.

Briesemeister, D; Sommermeyer, D; Loddenkemper, C; Loew, R; Uckert, W; Blankenstein, T; Kammertoens, T; (2011) Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis. INT J CANCER , 128 (2) 371 - 378. 10.1002/ijc.25350.

Brough, R; Frankum, JR; Sims, D; Mackay, A; Mendes-Pereira, AM; Bajrami, I; Costa-Cabral, S; (2011) Functional viability profiles of breast cancer. Cancer Discov , 1 (3) pp. 260-273. 10.1158/2159-8290.CD-11-0107.

Brown, NF; Marks, DJB; Smith, PJ; Bloom, SL; (2011) Splenomegaly. Br J Hosp Med (Lond) , 72 (11) M166-M169.

Brucoli, F; Hawkins, RM; James, CH; Wells, G; Jenkins, TC; Ellis, T; Hartley, JA; (2011) Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box. BIOORG MED CHEM LETT , 21 (12) 3780 - 3783. 10.1016/j.bmcl.2011.04.054.

Brunetto, A; Olmos, D; Arkenau, H-T; Tan, D; Yap, T; de Bono, J; Barriuso, J; (2011) Perceptions and referral trends into phase I oncology trials: results of a clinical survey. J Oncol , 2011 861401-. 10.1155/2011/861401.

Bustamante, J; Arias, AA; Vogt, G; Picard, C; Galicia, LB; Prando, C; Grant, AV; (2011) Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol , 12 (3) pp. 213-221. 10.1038/ni.1992.

C

Calabretta, B; Salomoni, P; (2011) Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors. LEUKEMIA LYMPHOMA , 52 54 - 59. 10.3109/10428194.2010.546913.

Calcagnino, M; O'Mahony, C; Coats, C; Cardona, M; Garcia, A; Janagarajan, K; Mehta, A; (2011) Exercise-Induced Left Ventricular Outflow Tract Obstruction in Symptomatic Patients With Anderson-Fabry Disease. J AM COLL CARDIOL , 58 (1) 88 - 89. 10.1016/j.jacc.2011.03.020.

Calleja-Agius, J; Muttukrishna, S; Pizzey, AR; Jauniaux, E; (2011) Pro- and antiinflammatory cytokines in threatened miscarriages. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY , 205 (1) 10.1016/j.ajog.2011.02.051.

Calvert, AH; (2011) Synthetic lethality in cancer treatment: Current status of PARP inhibitors. In: ANNALS OF ONCOLOGY. (pp. 13 - 13). OXFORD UNIV PRESS

Calvert, AH; Jackson, JC; Hutton, C; Swart, AM; Qian, W; Kwakye, C; Fossati, R; (2011) Evaluation of p53 mutation as a predictive biomarker for outcome to chemotherapy in ovarian cancer. J Clin Oncol , 29 (15_suppl) 10522-.

Calvert, H; Azzariti, A; (2011) The clinical development of inhibitors of poly(ADP-ribose) polymerase. ANNALS OF ONCOLOGY , 22 i53 - i59. 10.1093/annonc/mdq667.

Cantu, C; Ierardi, R; Alborelli, I; Fugazza, C; Cassinelli, L; Piconese, S; Bose, F; (2011) Sox6 enhances erythroid differentiation in human erythroid progenitors. BLOOD , 117 (13) pp. 3669-3679. 10.1182/blood-2010-04-282350.

Cappellini, MD; Bejaoui, M; Agaoglu, L; Canatan, D; Capra, M; Cohen, A; Drelichman, G; (2011) Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. BLOOD , 118 (4) 884 - 893. 10.1182/blood-2010-11-316646.

Carlin, LM; Evans, R; Milewicz, H; Fernandes, L; Matthews, DR; Perani, M; Levitt, J; (2011) A Targeted siRNA Screen Identifies Regulators of Cdc42 Activity at the Natural Killer Cell Immunological Synapse. Science Signaling , 4 (201) ra81-ra81. 10.1126/scisignal.2001729.

Carpenter, J-P; He, T; Kirk, P; Roughton, M; Anderson, LJ; de Noronha, SV; Sheppard, MN; (2011) On T2* magnetic resonance and cardiac iron. Circulation , 123 (14) pp. 1519-1528. 10.1161/CIRCULATIONAHA.110.007641.

Carpenter, L; Malladi, R; Yang, C-T; French, A; Pilkington, KJ; Forsey, RW; Sloane-Stanley, J; (2011) Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. BLOOD , 117 (15) pp. 4008-4011. 10.1182/blood-2010-08-299941.

Carrera-Marin, AL; Romay-Penabad, Z; Machin, S; Cohen, H; Weston-Davies, W; Pierangeli, SS; (2011) C5 Inhibitor rEV576 Ameliorates In Vivo Effects of Antiphospholipid Antibodies. In: (Proceedings) 75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals. (pp. S5-S5). WILEY-BLACKWELL

Carrera-Marin, AL; Romay-Penabad, Z; Weston-Davis, W; Machin, S; Cohen, H; Pierangeli, SS; (2011) C5 inhibitor rEV576 ameliorates in vivo effects of antiphospholipid antibodies. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 290.

Casper, CJ; Warner, TT; Taanman, JW; Nathwani, AC; (2011) Generation of iPS-derived dopaminergic neurons as an in-vitro model of Rapid-Onset Dystonia Parkinsonism. HUMAN GENE THERAPY , 22 (10) A42 - A43.

Catlin, SN; Busque, L; Gale, RE; Guttorp, P; Abkowitz, JL; (2011) The replication rate of human hematopoietic stem cells in vivo. BLOOD , 117 (17) 4460 - 4466. 10.1182/blood-2010-08-303537.

Cerone, MA; Burgess, DJ; Naceur-Lombardelli, C; Lord, CJ; Ashworth, A; (2011) High-throughput RNAi screening reveals novel regulators of telomerase. Cancer Res , 71 (9) pp. 3328-3340. 10.1158/0008-5472.CAN-10-2734.

Chakraverty, R; Mackinnon, S; (2011) Allogeneic Transplantation for Lymphoma. J CLIN ONCOL , 29 (14) 1855 - 1863. 10.1200/JCO.2010.32.8419.

Chapgier, A; (2011) Human Stat1 Deficiencies. [Book]. LAP Lambert Academic Publishing

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; Westrate, L; (2011) Hx, a novel fluorescent, minor groove and sequence specific recognition element: Design, synthesis, and DNA binding properties of p-anisylbenzimidazole imidazole/pyrrole-containing polyamides. In: (Proceedings) 242nd National Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; Westrate, L; (2011) Hx, a Novel Fluorescent, Minor Groove and Sequence Specific Recognition Element: Design, Synthesis, and DNA Binding Properties of p-Anisylbenzimidazole-imidazole/pyrrole-Containing Polyamides. BIOCHEMISTRY-US , 50 (15) 3127 - 3136. 10.1021/bi102028a.

Cheng, F; Pekkonen, P; Laurinavicius, S; Sugiyama, N; Henderson, S; Guenther, T; Rantanen, V; (2011) KSHV-Initiated Notch Activation Leads to Membrane-Type-1 Matrix Metalloproteinase-Dependent Lymphatic Endothelial-to-Mesenchymal Transition. CELL HOST & MICROBE , 10 (6) pp. 577-590. 10.1016/j.chom.2011.10.011.

Chew, SK; Rad, R; Futreal, PA; Bradley, A; Liu, P; (2011) Genetic screens using the piggyBac transposon. Methods , 53 (4) pp. 366-371. 10.1016/j.ymeth.2010.12.022.

Chua, MLK; Somaiah, N; A'Hern, R; Davies, S; Gothard, L; Yarnold, J; Rothkamm, K; (2011) Residual DNA and chromosomal damage in ex vivo irradiated blood lymphocytes correlated with late normal tissue response to breast radiotherapy. RADIOTHER ONCOL , 99 (3) 362 - 366. 10.1016/j.radonc.2011.05.071.

Chua, MLK; Somaiah, N; Bourne, S; Daley, F; A'Hern, R; Nuta, O; Davies, S; (2011) Inter-individual and inter-cell type variation in residual DNA damage after in vivo irradiation of human skin. RADIOTHER ONCOL , 99 (2) 225 - 230. 10.1016/j.radonc.2011.04.009.

Cire, S; Collins, MK; Buchholz, C; Galy, A; (2011) In vivo immunization against male antigens and GFP, with lentiviruses targeted to MHC class II positive cells. HUMAN GENE THERAPY , 22 (10) A69-A69.

Cire, S; Collins, MK; Buchholz, CJ; Galy, A; (2011) An experimental model set-up to study MHC class II targeted gene transfer in antigen-presenting-cells. In: (Proceedings) 10th Annual Congress of the French-Society-of-Cell-and-Gene-Therapy (SFTCG). (pp. A24-A25). MARY ANN LIEBERT INC

Cohen, H; (2011) Current best practice in oral anticoagulation. In: (Proceedings) Sysmex user symposium.

Cohen, H; (2011) Heritable thrombotic risk factors: influence on antiphospholipid syndrome pregnancy outcomes and treatment in pregnancy. Presented at: VIII European Forum on antiphospholipid antibodies, Padua.

Cohen, H; (2011) Heritable thrombotic risk factors: influence on antiphospholipid syndrome pregnancy outcomes and treatment in pregnancy. Presented at: VIII European Forum on antiphospholipid antibodies, Padua.

Cohen, H; (2011) New oral anticoagulants in antiphospholipid syndrome: the RAPS trisl. [Lecture]. Presented at: APS ACTION 2nd annual summit, Chicago.

Cohen, H; (2011) Placental vascular mediated late obstetric morbidity: management and outcomes. [Lecture]. Presented at: British society for haematology obstetric subgroup, Leicester.

Cohen, H; (2011) SHOT 2010 and improving patient safety through interventions based on SHOT data. [Lecture]. Presented at: SHOT annual symposium, London.

Conde, L; Bevan, S; Sitzer, M; Klopp, N; Illig, T; Thiery, J; Seissler, J; (2011) Novel associations for coronary artery disease derived from genome wide association studies are not associated with increased carotid intima-media thickness, suggesting they do not act via early atherosclerosis or vessel remodeling. Atherosclerosis , 219 (2) pp. 684-689. 10.1016/j.atherosclerosis.2011.08.031.

Conde, L; Bracci, PM; Halperin, E; Skibola, CF; (2011) A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases. Genomics , 98 (1) pp. 9-14. 10.1016/j.ygeno.2011.03.007.

Confer, DL; Shaw, BE; Pamphilon, DH; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. Bone Marrow Transplantation , 46 (11) pp. 1409-1412. 10.1038/bmt.2010.323.

Confer, DL; Shaw, BE; Pamphilon, DH; Clinical Working Grp WMDA, ; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. BONE MARROW TRANSPL , 46 (11) 1409 - 1412. 10.1038/bmt.2010.323.

Conrad, DF; Keebler, JEM; DePristo, MA; Lindsay, SJ; Zhang, Y; Casals, F; Idaghdour, Y; (2011) Variation in genome-wide mutation rates within and between human families. Nat Genet , 43 (7) pp. 712-714. 10.1038/ng.862.

Cook, G; Kirkland, K; Lee, J; Pearce, RM; Apperley, JF; Clark, RE; Mackinnon, S; (2011) Allogeneic Stem Cell Transplantation Induces Long Term Survival in Pateitns with Advanced Chronic Myeloid Leukaemia: A Study of the British Society for Blood and Marrow Transplantation. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). (pp. p. 1764). AMER SOC HEMATOLOGY

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Downstream of human NDR kinases Impacting on c-myc and p21 protein stability to control cell cycle progression. CELL CYCLE , 10 (12) 1897 - 1904. 10.4161/cc.10.12.15826.

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Human NDR Kinases Control G(1)/S Cell Cycle Transition by Directly Regulating p21 Stability. MOL CELL BIOL , 31 (7) 1382 - 1395. 10.1128/MCB.01216-10.

Cortese, R; Lewin, J; Backdahl, L; Krispin, M; Wasserkort, R; Eckhardt, F; Beck, S; (2011) Genome-Wide Screen for Differential DNA Methylation Associated with Neural Cell Differentiation in Mouse. PLOS ONE , 6 (10) , Article e26002. 10.1371/journal.pone.0026002. Green open access
file

Counsell, N; Cortina-Borja, M; Lehtonen, A; Stein, A; (2011) Modelling psychiatric measures using Skew-Normal distributions. EUR PSYCHIAT , 26 (2) 112 - 114. 10.1016/j.eurpsy.2010.08.006.

Coward, J; Kulbe, H; Chakravarty, P; Leader, D; Vassileva, V; Leinster, DA; Thompson, R; (2011) Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer. CLINICAL CANCER RESEARCH , 17 (18) pp. 6083-6096. 10.1158/1078-0432.CCR-11-0945.

Cox, S.T.; (2011) The relevance and impact of MICA allele mismatching and MICA antibodies on renal transplantation outcome. Doctoral thesis, UCL (University College London). Green open access
file

Cox, ST; Stephens, HAF; Fernando, R; Karasu, A; Harber, M; Howie, AJ; Powis, S; (2011) Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. Hum Immunol , 72 (10) pp. 827-834. 10.1016/j.humimm.2011.05.004.

Cuomo, ME; Platt, GM; Pearl, LH; Mittnacht, S; (2011) Cyclin-Cyclin-dependent Kinase Regulatory Response Is Linked to Substrate Recognition. J BIOL CHEM , 286 (11) 9713 - 9725. 10.1074/jbc.M110.173872. Gold open access

D

Dancey, G.S.; (2011) Novel radioimmunotherapy for lymphoma and solid tumours both as a single agent and in combination with the vascular disrupting agents. Doctoral thesis, UCL (University College London). Green open access
file

Danecek, P; Auton, A; Abecasis, G; Albers, CA; Banks, E; DePristo, MA; Handsaker, RE; (2011) The variant call format and VCFtools. Bioinformatics , 27 (15) pp. 2156-2158. 10.1093/bioinformatics/btr330.

Danovi, D; Folarin, A; Pollard, S; (2011) Live Image Based Screen on Glioblastoma Stem Cells. In: EUROPEAN JOURNAL OF CANCER. (pp. S171 - S171). ELSEVIER SCI LTD

David, AL; McIntosh, J; Peebles, DM; Cook, T; Waddington, S; Weisz, B; Wigley, V; (2011) Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep. HUM GENE THER , 22 (4) 419 - 426. 10.1089/hum.2010.007.

Davies, T; Poles, D; Watt, A; Ball, J; Mistry, H; Knowles, S; Cohen, H; (2011) SHOT participation and benchmarking data 2010. In: (Proceedings) British Blood Transfusion Society.

De, S; Varsally, W; Falciani, F; Brogna, S; (2011) Ribosomal proteins' association with transcription sites peaks at tRNA genes in Schizosaccharomyces pombe. RNA , 17 (9) pp. 1713-1726. 10.1261/rna.2808411.

De Bono, JS; Logothetis, CJ; Molina, A; Fizazi, K; North, S; Chu, L; Chi, KN; (2011) Abiraterone and Increased Survival in Metastatic Prostate Cancer. NEW ENGLAND JOURNAL OF MEDICINE , 364 (21) pp. 1995-2005.

De Gobbi, M; Garrick, D; Lynch, M; Vernimmen, D; Hughes, JR; Goardon, N; Luc, S; (2011) Generation of bivalent chromatin domains during cell fate decisions. EPIGENETICS & CHROMATIN , 4 (ARTN 9) 10.1186/1756-8935-4-9. Gold open access

Dedes, KJ; Wetterskog, D; Ashworth, A; Kaye, SB; Reis-Filho, JS; (2011) Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol , 8 (5) pp. 261-271. 10.1038/nrclinonc.2010.216.

Dedes, KJ; Wilkerson, PM; Wetterskog, D; Weigelt, B; Ashworth, A; Reis-Filho, JS; (2011) Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. Cell Cycle , 10 (8) pp. 1192-1199. 10.4161/cc.10.8.15273.

Della Peruta, M; Binny, C; Nathwani, D; Chokshi, S; McIntosh, J; Rosales, C; Davidoff, AM; (2011) The development of a tumour-selective recombinant adeno-associated virus vector to target hepatocellular carcinoma. HUMAN GENE THERAPY , 22 (10) A113 - A113.

Deltcheva, E; Chylinski, K; Sharma, CM; Gonzales, K; Chao, Y; Pirzada, ZA; Eckert, MR; (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature , 471 (7340) pp. 602-607. 10.1038/nature09886.

Denbo, JW; Williams, RF; Orr, WS; Sims, TL; Ng, CY; Zhou, JF; Spence, Y; (2011) Continuous local delivery of interferon-beta stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection model. SURGERY , 150 (3) 497 - 504. 10.1016/j.surg.2011.07.044.

Deugnier, Y; Turlin, B; Ropert, M; Cappellini, MD; Porter, JB; Giannone, V; Zhang, Y; (2011) Improvement in Liver Pathology of Patients With beta-Thalassemia Treated With Deferasirox for at Least 3 Years. GASTROENTEROLOGY , 141 (4) 1202-U618. 10.1053/j.gastro.2011.06.065.

Dina, R; Gudi, M; Kocjan, G; Schmitt, F; Vielh, P; (2011) Reply to: The danger to cytopathology of overspecialization and its relevance for histopathology Authors' response. CYTOPATHOLOGY , 22 (3) 209 - 210. 10.1111/j.1365-2303.2011.00875.x.

Dina, R; Gudi, M; Kocjan, G; Schmitt, F; Vielh, P; (2011) The danger to cytopathology of over-specialization and its relevance for histopathology. CYTOPATHOLOGY , 22 (2) 140 - 140. 10.1111/j.1365-2303.2011.00865.x.

Doebroessy, M; Klein, A; Janghra, N; Nikkhah, G; Dunnett, SB; (2011) Validating the use of M4-BAC-GFP mice as tissue donors in cell replacement therapies in a rodent model of Huntington's disease. JOURNAL OF NEUROSCIENCE METHODS , 197 (1) pp. 6-13. 10.1016/j.jneumeth.2011.01.015.

Donaldson, J; Khan, WS; Tailor, H; Hughes, DA; Mehta, AB; Maruthainar, N; (2011) Gaucher disease: outcome following total hip replacements and effect of enzyme replacement therapy in a cohort of UK patients. HIP INTERNATIONAL , 21 (6) pp. 665-671. 10.5301/HIP.2011.8826.

Dragovic, RA; Gardiner, C; Brooks, AS; Tannetta, DS; Ferguson, DJP; Hole, P; Carr, B; (2011) Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine: Nanotechnology, Biology and Medicine , 7 (6) pp. 780-788. 10.1016/j.nano.2011.04.003. Green open access
file

Drebes, A; Khalil, A; O'Brien, P; Cohen, H; (2011) Management and outcomes in women with late obstetric morbidity associated with a thrombotic basis. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 2). WILEY-BLACKWELL

Drebes, A; Khalil, A; O'Brien, P; Cohen, H; (2011) Management and outcomes in women with late obstetric morbidity associated with a thrombotic basis. In: (pp. p. 2).

Drebes, AB; Khalil, A; O'Brien, P; Cohen, H; (2011) Late obstetric morbidity in women with and without inherited or acquired thrombophilia: management and outcomes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 631.

Drew, Y; Ledermann, JA; Jones, A; Hall, G; Jayson, GC; Highley, M; Rea, D; (2011) Phase II trial of the poly(ADP-ribose) polymerase (PARP) inhibitor AG-014699 in BRCA 1 and 2-mutated, advanced ovarian and/or locally advanced or metastatic breast cancer. J Clin Oncol , 29 (15_suppl) 3104-.

Drew, Y; Ledermann, JA; Jones, A; Hall, G; Jayson, GC; Highley, M; Rea, D; (2011) Phase II trial of the poly(ADP-ribose) polymerase (PARP) inhibitor AG-014699 in BRCA 1 and 2-mutated, advanced ovarian and/or locally advanced or metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

Duarte, RF; Shaw, BE; Marin, P; Kottaridis, P; Ortiz, M; Morante, C; Delgado, J; (2011) Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. BONE MARROW TRANSPL , 46 (1) 52 - 58. 10.1038/bmt.2010.54.

Dudderidge, J; Vasdev, N; Wollenschlaeger, A; Okoturo, O; Kelly, J; Stoeber, K; (2011) Diagnosis of bladder cancer by combined detection of minichromosome maintenance 5 protein and NMP22 in urine. In: BJU INTERNATIONAL. (pp. 7 - 7). WILEY-BLACKWELL

Dudderidge, TJ; Beatty, J; Larkin, J; Gore, M; Christmas, TJ; (2011) Surgery for loco-regional recurrence after nephrectomy for renal cell carcinoma (RCC): outcomes after initial incomplete resection and implantational recurrences. In: BJU INTERNATIONAL. (pp. 42 - 42). WILEY-BLACKWELL

Dudderidge, TJ; Kelly, J; Wollenschlaeger, A; Leung, H; Okoturo, O; Prevost, T; Prevost, T; (2011) DIAGNOSIS OF BLADDER CANCER BY COMBINED DETECTION OF MINICHROMOSOME MAINTENANCE 5 PROTEIN AND NMP22 IN URINE. EUR UROL SUPPL , 10 (2) 73 - 74.

Dudderidge, TJ; Robertson, N; Lavan, L; Rashid, T; Hawizy, A; Ogden, CW; (2011) Robotic prostatectomy delivers excellent outcomes and short hospital stay. Access in the NHS should be expanded not limited due to consumable costs. In: BJU INTERNATIONAL. (pp. 34 - 35). WILEY-BLACKWELL

Duhamel, L.A.E.; (2011) The role of LKB1 in the pathogenesis of Osteosarcoma. Doctoral thesis, UCL (University College London). Green open access
file

Dunn, JM; Banks, MR; Oukrif, D; Mackenzie, GD; Thorpe, S; Rodriguez-Justo, M; Winstanley, A; (2011) Radiofrequency ablation is effective for the treatment of high-grade dysplasia in Barrett's esophagus after failed photodynamic therapy. ENDOSCOPY , 43 (7) 627 - 630. 10.1055/s-0030-1256443.

Dunn, JM; Bird-Lieberman, EL; Coleman, HG; Oukrif, D; Arthur, K; Lao-Sirieix, P; Murray, L; (2011) IMAGE CYTOMETRY DNA PLOIDY ABNORMALITIES ARE AN INDEPENDENT RISK FACTOR FOR CANCER PROGRESSION IN NON-DYSPLASTIC BARRETT'S OESOPHAGUS AND LOW GRADE DYSPLASIA: RESULTS OF THE NIBR STUDY. In: GUT. (pp. ? - ?). B M J PUBLISHING GROUP

Dunn, JM; Bird-Lieberman, EL; Lao-Sirieix, P; Mulholland, HG; Oukrif, D; Walker, EC; Varghese, S; (2011) Phase 3 Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus. In: GASTROENTEROLOGY. (pp. S136 - S136). W B SAUNDERS CO-ELSEVIER INC

Dunn, JM; Hveem, T; Pretorius, M; Oukrif, D; Nielsen, B; Albregtsen, F; Lovat, LB; (2011) Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus. BRIT J CANCER , 105 (8) 1218 - 1223. 10.1038/bjc.2011.353.

Dunn, JM; Mackenzie, GD; Thorpe, S; Austwick, M; Mosse, CA; Oukrif, D; Rodriguez-Justo, M; (2011) A Randomised Controlled Trial of ALA V Photofrin PDT for High Grade Dysplasia in Barrett's Esophagus. In: GASTROENTEROLOGY. (pp. S215 - S216). W B SAUNDERS CO-ELSEVIER INC

Dunn, JM; Mackenzie, GD; Thorpe, S; Austwick, M; Mosse, CA; Oukrif, D; Winstanley, A; (2011) A RANDOMISED CONTROLLED TRIAL OF ALA VERSUS PHOTOFRIN PDT FOR HIGH GRADE DYSPLASIA IN BARRETT'S OESOPHAGUS. In: GUT. (pp. A172 - A172). B M J PUBLISHING GROUP

Dunn, JM; McDonald, SA; Oukrif, D; Haidry, RJ; Butt, MA; Lovat, E; Lovat, LB; (2011) PLK-1 IS UPREGULATED IN BARRETT'S ADENOCARCINOMA AND IS A SURROGATE MARKER OF ANEUPLOIDY. In: GUT. (pp. ? - ?). B M J PUBLISHING GROUP

Dunn, JM; McDonald, SA; Oukrif, D; Haidry, RJ; Butt, MA; Lovat, L; Williams, GH; (2011) Plk-1 is Upregulated in Barrett's Adenocarcinoma and is a Surrogate Marker of Aneuploidy. In: GASTROENTEROLOGY. (pp. S667 - S667). W B SAUNDERS CO-ELSEVIER INC

du Parcq, PA; Jones, P; Nelson, J; Miller, K; Diss, T; (2011) EGFR mutation in non-small cell lung cancer: one year of laboratory testing. LUNG CANCER , 71 S3 - S3.

E

El-Sharkawi, D; Basu, S; Qian, W; D'Sa, S; Hoskin, P; Ardeshna, K; (2011) LACTATE DEHYDROGENASE LEVELS DO NOT PREDICT RELAPSE IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA. In: ANNALS OF ONCOLOGY. (pp. 223 - 223). OXFORD UNIV PRESS

El-Sharkawi, D; Ramsay, A; Cwynarski, K; Hughes, D; Prentice, A; Davies, N; Goode, A; (2011) Clinico-pathologic characteristics of patients with hepatic lymphoma diagnosed using image-guided liver biopsy techniques. LEUKEMIA LYMPHOMA , 52 (11) 2130 - 2134. 10.3109/10428194.2011.589546.

Elliott, P; Baker, R; Pasquale, F; Quarta, G; Ebrahim, H; Mehta, AB; Hughes, DA; (2011) Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey. HEART , 97 (23) 1957 - 1960. 10.1136/heartjnl-2011-300364.

Endesfelder, D; McGranahan, N; Birkbak, NJ; Szallasi, Z; Kschischo, M; Graham, TA; Swanton, C; (2011) A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variables. ONCOTARGET , 2 (7) pp. 529-537.

Ertemi, H; Mumtaz, FH; Howie, AJ; Mikhailidis, DP; Thompson, CS; (2011) Effect of Angiotensin II and its Receptor Antagonists on Human Corpus Cavernous Contractility and Oxidative Stress: Modulation of Nitric Oxide Mediated Relaxation. J UROLOGY , 185 (6) 2414 - 2420. 10.1016/j.juro.2011.02.2645.

Escors, D; Bricogne, C; Arce, F; Kochan, G; Karwacz, K; (2011) On the Mechanism of T cell receptor down-modulation and its physiological significance. J Biosci Med , 1 (1)

Evans, IM; Yamaji, M; Britton, G; Pellet-Many, C; Lockie, C; Zachary, IC; Frankel, P; (2011) Neuropilin-1 Signaling through p130(Cas) Tyrosine Phosphorylation Is Essential for Growth Factor-Dependent Migration of Glioma and Endothelial Cells. MOLECULAR AND CELLULAR BIOLOGY , 31 (6) pp. 1174-1185. 10.1128/MCB.00903-10.

Evans, P; Cindrova-Davies, T; Muttukrishna, S; Burton, GJ; Porter, J; Jauniaux, E; (2011) Hepcidin and iron species distribution inside the first-trimester human gestational sac. MOL HUM REPROD , 17 (4) 227 - 232. 10.1093/molehr/gaq101.

F

Faelber, K; Posor, Y; Gao, S; Held, M; Roske, Y; Schulze, D; Haucke, V; (2011) Crystal structure of nucleotide-free dynamin. Nature , 477 (7366) pp. 556-560. 10.1038/nature10369.

Farren, TW; Liu, F; Macey, MG; Jenner, M; Prentice, A; Nathwani, A; Agrawal, SG; (2011) CD160: a novel approach to minimal residual disease (MRD) assessment in chronic lymphocytic leukaemia (CLL). In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 72). WILEY-BLACKWELL

Feber, A; Wilson, GA; Zhang, L; Presneau, N; Idowu, B; Down, TA; Rakyan, VK; (2011) Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors. Genome Research , 21 (4) pp. 515-524. 10.1101/gr.109678.110. Gold open access

Feber, A; Xi, LQ; Pennathur, A; Gooding, WE; Bandla, S; Wu, MX; Luketich, JD; (2011) MicroRNA Prognostic Signature for Nodal Metastases and Survival in Esophageal Adenocarcinoma. ANNALS OF THORACIC SURGERY , 91 (5) 1523 - 1530. 10.1016/j.athoracsur.2011.01.056.

Feng, G; Nadig, SN; Backdahl, L; Beck, S; Francis, RS; Schiopu, A; Whatcott, A; (2011) Functional Regulatory T Cells Produced by Inhibiting Cyclic Nucleotide Phosphodiesterase Type 3 Prevent Allograft Rejection. SCI TRANSL MED , 3 (83) , Article 83ra40. 10.1126/scitranslmed.3002099.

Feng, H; Hu, B; Liu, K-W; Li, Y; Lu, X; Cheng, T; Yiin, J-J; (2011) Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans. J Clin Invest , 121 (12) pp. 4670-4684. 10.1172/JCI58559.

Fenton, TR; Gout, IT; (2011) Functions and regulation of the 70 kDa ribosomal S6 kinases. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY , 43 (1) pp. 47-59. 10.1016/j.bioce1.2010.09.018.

Fernandes, E; Goold, HD; Kissenpfennig, A; Malissen, B; Dyson, J; Bennett, CL; (2011) The Role of Direct Presentation by Donor Dendritic Cells in Rejection of Minor Histocompatibility Antigen-Mismatched Skin and Hematopoietic Cell Grafts. Transplantation , 91 (2) 154 - 160. 10.1097/TP.0b013e318201ac27. Green open access
file

Ferrer, IR; Araki, K; Ford, ML; (2011) Paradoxical aspects of rapamycin immunobiology in transplantation. Am J Transplant , 11 (4) pp. 654-659. 10.1111/j.1600-6143.2011.03473.x.

Ferrer, IR; Wagener, ME; Song, M; Kirk, AD; Larsen, CP; Ford, ML; (2011) Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade. Proc Natl Acad Sci U S A , 108 (51) pp. 20701-20706. 10.1073/pnas.1105500108.

Fielding, AK; (2011) Current Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA , 25 (6) 1255-+. 10.1016/j.hoc.2011.09.008.

Fielding, AK; (2011) Current Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM pp. 231-237. 10.1182/asheducation-2011.1.231.

Fielding, AK; (2011) Philadelphia-Positive Acute Lymphoblastic Leukemia-Is Bone Marrow Transplant Still Necessary? BIOL BLOOD MARROW TR , 17 (1) S84 - S88. 10.1016/j.bbmt.2010.11.023.

Fielding, AK; (2011) Recommendations of the European Working Group for Adult ALL. In: Gökbuget, N, (ed.) Recommendations of the European Working Group for Adult ALL.

Fisher, R; Larkin, J; Swanton, C; (2011) Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity. EPMA J , 3 (1) 1-. 10.1007/s13167-011-0137-3.

Flicek, P; Amode, MR; Barrell, D; Beal, K; Brent, S; Chen, Y; Clapham, P; (2011) Ensembl 2011. Nucleic Acids Res , 39 (Database) D800-D806. 10.1093/nar/gkq1064.

Flutter, B; Edwards, N; Zhang, L; Sivakumaran, S; Croft, M; Sykes, M; Chakraverty, R; (2011) Enforced Co-Stimulation and Co-Inhibitory Blockade Synergize to Enhance the Functions of Exhausted CTL. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 833-834). AMER SOC HEMATOLOGY

Flutter, B; Velica, P; Chakraverty, R; (2011) Memory lapses in graft-versus-host disease. EUR J IMMUNOL , 41 (9) 2530 - 2534. 10.1002/eji.201141946.

Flutter, BR; Edwards, N; Zhang, L; Sivakumaran, S; Croft, M; Sykes, M; Chakraverty, R; (2011) Enforced co-stimulation and co-inhibitory blockade synergise to enhance the functions of exhausted CTL. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 38). WILEY-BLACKWELL

Foley, JH; Cook, PF; Nesheim, ME; (2011) Kinetics of Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa)-catalyzed Cleavage of C-terminal Lysine Residues of Fibrin Degradation Products and Removal of Plasminogen-binding Sites. Journal of Biological Chemistry , 286 (22) pp. 19280-19286. 10.1074/jbc.M110.215061.

Foroni, L; Wilson, G; Gerrard, G; Mason, J; Grimwade, D; White, HE; de Castro, DG; (2011) Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 153 (2) pp. 179-190. 10.1111/j.1365-2141.2011.08603.x.

Forster, MD; Dedes, K; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, C; (2011) Treatment with the PARP inhibitor olaparib in a patient with PTEN-deficient endometrial cancer. Nature Reviews Clinical Oncology , 8 (5) pp. 302-306.

Forster, MD; Dedes, KJ; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; Poole, CJ; (2011) Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol , 8 (5) pp. 302-306. 10.1038/nrclinonc.2011.42.

Furniss, D; Blandford, AE; Mayer, A; (2011) Considering Unremarkable Computing for Healthcare. In: (Proceedings) Workshop on Interactive Systems in Healthcare (WISH), Workshop at AMIA 2011 Annual Symposium.

Furniss, D; Blandford, AE; Rajkomar, A; Vincent, C; Mayer, A; (2011) The visible and the invisible: Distributed Cognition for medical devices. In: Blandford, A and De Pietro, G and Gallo, L and Gimblett, A and Oladimeji, P and Thimbleby, H, (eds.) EICS4Med 2011: Proceedings of the 1st International Workshop on Engineering Interactive Computing Systems for Medicine and Health Care: Pisa, Italy: June, 2011. (pp. pp. 1-6). CEUR Green open access
file

Furstenberg, A; Walsh, SB; Howie, A; Jones, G; Unwin, RJ; (2011) Calcineurin-Inhibitor Induced Hypertension, Hyperkalaemia and Metabolic Acidosis Is Caused by Overactivity of the Sodium Chloride Cotransporter. In: AMERICAN JOURNAL OF TRANSPLANTATION. (pp. 406 - 406). WILEY-BLACKWELL

Furuse, J; Okusaka, T; Bridgewater, J; Taketsuna, M; Wasan, H; Koshiji, M; Valle, J; (2011) Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , 80 (1) pp. 31-39. 10.1016/j.critrevonc.2010.10.009.

G

Gadaleta, RM; Oldenburg, B; Willemsen, ECL; Spit, M; Murzilli, S; Salvatore, L; Klomp, LWJ; (2011) Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine. Biochim Biophys Acta , 1812 (8) pp. 851-858. 10.1016/j.bbadis.2011.04.005.

Gal, A; Hughes, DA; Winchester, B; (2011) Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group. J INHERIT METAB DIS , 34 (2) 509 - 514. 10.1007/s10545-010-9261-9.

Galavotti, S; Shaked-Rabi, M; Tulchinsky, E; Brandner, S; Jones, C; Salomoni, P; (2011) THE METABOLIC AUTOPHAGY PATHWAY REGULATES MIGRATION AND INVASION IN GLIOMA. In: NEURO-ONCOLOGY. (pp. 10 - 10). OXFORD UNIV PRESS INC

García-Gómez, JJ; Babiano, R; Lebaron, S; Froment, C; Monsarrat, B; Henry, Y; de la Cruz, J; (2011) Nop6, a component of 90S pre-ribosomal particles, is required for 40S ribosomal subunit biogenesis in Saccharomyces cerevisiae. RNA Biol , 8 (1) pp. 112-124.

García-Gómez, JJ; Lebaron, S; Froment, C; Monsarrat, B; Henry, Y; de la Cruz, J; (2011) Dynamics of the putative RNA helicase Spb4 during ribosome assembly in Saccharomyces cerevisiae. Mol Cell Biol , 31 (20) pp. 4156-4164. 10.1128/MCB.05436-11.

Gardiner, C; Tannetta, DS; Harrison, P; Redman, CWG; Sargent, IL; (2011) Increased levels of tissue factor activity on syncytiotrophoblast microvesicles released into the maternal circulation during pre-eclampsia. In: (pp. p. 169).

Gardiner, C; Tannetta, DS; Simms, CA; Harrison, P; Redman, CWG; Sargent, IL; (2011) Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity. PLoS One , 6 (10) , Article e26313. 10.1371/journal.pone.0026313. Green open access
file

Gelderblom, H; Jinks, RC; Sydes, M; Bramwell, VHC; van Glabbeke, M; Grimer, RJ; Hogendoorn, PCW; (2011) Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. Eur J Cancer , 47 (6) pp. 895-902. 10.1016/j.ejca.2010.11.036.

Gennarino, V; Sardiello, M; Mutarelli, M; (2011) HOCTAR database: A unique resource for microRNA target prediction. Gene

Gerlach, B; Cordier, SM; Schmukle, AC; Emmerich, CH; Rieser, E; Haas, TL; Webb, AI; (2011) Linear ubiquitination prevents inflammation and regulates immune signalling. Nature , 471 pp. 591-596. 10.1038/nature09816.

Germani, G; Hytiroglou, P; Fotiadu, A; Burroughs, AK; Dhillon, AP; (2011) Assessment of Fibrosis and Cirrhosis in Liver Biopsies: An Update. SEMIN LIVER DIS , 31 (1) 82 - 90. 10.1055/s-0031-1272836.

Gerrard, G; Mudge, K; Stewart, R; Foskett, P; Stevens, D; Khorashad, JS; Szydlo, R; (2011) Duplex quantitative PCR for molecular monitoring of BCR-ABL1-associated hematological malignancies. AMERICAN JOURNAL OF HEMATOLOGY , 86 (3) pp. 313-315. 10.1002/ajh.21954.

Gillmore, R; Stuart, S; Kirkwood, A; Hameeduddin, A; Woodward, N; Burroughs, AK; Meyer, T; (2011) EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolisation. JOURNAL OF HEPATOLOGY , 55 (6) pp. 1309-1316.

Glynne-Jones, R; Sebag-Montefiore, D; Adams, R; McDonald, A; Gollins, S; James, R; Northover, JMA; (2011) "MIND THE GAP"-THE IMPACT OF VARIATIONS IN THE DURATION OF THE TREATMENT GAP AND OVERALL TREATMENT TIME IN THE FIRST UK ANAL CANCER TRIAL (ACT I). INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , 81 (5) pp. 1488-1494. 10.1016/j.ijrobp.2010.07.1995.

Goardon, N; Marchi, E; Atzberger, A; Quek, L; Schuh, A; Soneji, S; Woll, P; (2011) Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia. CANCER CELL , 19 (1) pp. 138-152. 10.1016/j.ccr.2010.12.012.

Goh, V; Shastry, M; Engledow, A; Reston, J; Wellsted, DM; Peck, J; Endozo, R; (2011) Commercial software upgrades may significantly alter Perfusion CT parameter values in colorectal cancer. Eur Radiol , 21 (4) pp. 744-749. 10.1007/s00330-010-1967-4.

Goldstein, R; Meyer, T; (2011) Role of everolimus in pancreatic neuroendocrine tumors. EXPERT REVIEW OF ANTICANCER THERAPY , 11 (11) pp. 1653-1665. 10.1586/ERA.11.145.

Golubnitschaja, O; Swanton, C; Danesi, R; Costigliola, V; (2011) Promoting predictive, preventive and personalised medicine: European event of global importance. EPMA J , 2 (2) pp. 131-136. 10.1007/s13167-011-0088-8.

Goold, HD; Escors, D; Conlan, TJ; Chakraverty, R; Bennett, CL; (2011) Conventional Dendritic Cells Are Required for the Activation of Helper-Dependent CD8 T Cell Responses to a Model Antigen After Cutaneous Vaccination with Lentiviral Vectors. Journal of Immunology , 186 (8) 4565 - 4572. 10.4049/jimmunol.1002529.

Grabher, C; Payne, EM; Johnston, AB; Bolli, N; Lechman, E; Dick, JE; Kanki, JP; (2011) Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb. LEUKEMIA , 25 (3) pp. 506-514. 10.1038/leu.2010.280.

Graham, TA; Humphries, A; Sanders, T; Rodriguez-Justo, M; Tadrous, PJ; Preston, SL; Novelli, MR; (2011) Use of methylation patterns to determine expansion of stem cell clones in human colon tissue. Gastroenterology , 140 (4) 1241-1250.e1-9-. 10.1053/j.gastro.2010.12.036.

Gravel, S; Henn, BM; Gutenkunst, RN; Indap, AR; Marth, GT; Clark, AG; Yu, F; (2011) Demographic history and rare allele sharing among human populations. Proceedings of the National Academy of Sciences , 108 (29) pp. 11983-11988. 10.1073/pnas.1019276108.

Green, CL; Evans, CM; Zhao, L; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2011) The prognostic significance of IDH2 mutations in AML depends on the location of the mutation. BLOOD , 118 (2) 409 - 412. 10.1182/blood-2010-12-322479.

Green, L; De Lord, C; Clark, B; Cadet, E; Rochette, J; Thein, SL; (2011) Transient aplastic crisis as presentation of a previously unknown G6PD deficiency with iron overload. Br J Haematol , 154 (3) 288-. 10.1111/j.1365-2141.2011.08666.x.

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 3). WILEY-BLACKWELL

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of a new automated thrombin generation assay that is sensitive to activated protein C resistance. In: (pp. p. 3).

Green, L; Lawrie, AS; Mackie, IJ; Ryland, K; Cohen, H; Liesner, R; Machin, SJ; (2011) Development and application of an automated thrombin generation assay which is sensitive to defects of protein C pathway. In: J THROMB HAEMOST. (pp. 154 - 154). WILEY-BLACKWELL

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The effect of total hip and knee replacement surgery and dabigatran on thrombin generation. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 658.

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2011) The impact of dabigatran on thrombin generation and other haemostatic markers after orthopaedic surgery. In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 76). WILEY-BLACKWELL

Grimmett, C; Bridgewater, J; Steptoe, A; Wardle, J; (2011) Lifestyle and quality of life in colorectal cancer survivors. QUAL LIFE RES , 20 (8) 1237 - 1245. 10.1007/s11136-011-9855-1.

Groves, AM; Shastry, M; Rodriguez-Justo, M; Malhotra, A; Endozo, R; Davidson, T; Kelleher, T; (2011) F-18-FDG PET and biomarkers for tumour angiogenesis in early breast cancer. EUR J NUCL MED MOL I , 38 (1) 46 - 52. 10.1007/s00259-010-1590-2.

Guerra, C; Collado, M; Navas, C; Schuhmacher, AJ; Hernández-Porras, I; Cañamero, M; Rodriguez-Justo, M; (2011) Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell , 19 (6) pp. 728-739. 10.1016/j.ccr.2011.05.011.

Gunaratnam, M; de la Fuente, M; Hampel, SM; Todd, AK; Reszka, AP; Schätzlein, A; Neidle, S; (2011) Targeting pancreatic cancer with a G-quadruplex ligand. Bioorg Med Chem , 19 (23) pp. 7151-7157. 10.1016/j.bmc.2011.09.055.

Guppy, A; Jamal-Hanjani, M; Pickering, L; (2011) Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer. Future Oncol , 7 (6) pp. 727-736. 10.2217/fon.11.49.

Gutierrez, A; Grebliunaite, R; Feng, H; Kozakewich, E; Zhu, S; Guo, F; Payne, E; (2011) Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med , 208 (8) pp. 1595-1603. 10.1084/jem.20101691.

Gutierrez-Gonzalez, L; Graham, TA; Rodriguez-Justo, M; Leedham, SJ; Novelli, MR; Gay, LJ; Ventayol-Garcia, T; (2011) The Clonal Origins of Dysplasia From Intestinal Metaplasia in the Human Stomach. GASTROENTEROLOGY , 140 (4) 1251-+. 10.1053/j.gastro.2010.12.051.

Gómez-López, S; Wiskow, O; Favaro, R; Nicolis, SK; Price, DJ; Pollard, SM; Smith, A; (2011) Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells In vitro. Glia , 59 (11) pp. 1588-1599. 10.1002/glia.21201.

H

Hackshaw, A; Kirkwood, A; (2011) Interpreting and reporting clinical trials with results of borderline significance. BMJ , 343 d3340-.

Hackshaw, A; Rodeck, C; Boniface, S; (2011) Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. HUM REPROD UPDATE , 17 (5) 589 - 604. 10.1093/humupd/dmr022. Gold open access

Hackshaw, A; Roughton, M; Forsyth, S; Monson, K; Reczko, K; Sainsbury, R; Baum, M; (2011) Long-term benefits of 5 years of tamoxifen: 10 year follow up of a large randomised trial in women aged at least 50 years with early breast cancer. Journal of Clinical Oncology , 29 (13) pp. 1657-1663. (In press).

Hagerstrom, MN; Rorby, E; May, G; Tipping, A; Brown, J; Karlsson, G; Enver, T; (2011) Gata2 Is a Direct Target for Smad-Mediated TGF beta Signaling in Hematopoietic Stem/Progenitor Cells. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 580). AMER SOC HEMATOLOGY

Hall, A; Isgro, G; Morris, R; Burroughs, AK; Dhillon, AP; (2011) SIZE OF SAMPLE REQUIRED FOR DIGITAL IMAGE ANALYSIS MEASUREMENT OF LIVER COLLAGEN IN CIRRHOSIS. In: (Proceedings) 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). (pp. S133-S133). ELSEVIER SCIENCE BV

Harding, J.; (2011) Small RNAs as regulators of early vertebrate development. Doctoral thesis, UCL (University College London). Green open access
file

Harrison, JD; Rodriguez-Justo, M; (2011) Commentary on IgG4-related sialadenitis: Mikulicz's disease, Küttner's tumour, and eponymy. Histopathology , 58 (7) pp. 1164-1166. 10.1111/j.1365-2559.2011.03824.x.

Harrison, P; Mackie, I; Mumford, A; Briggs, C; Liesner, R; Winter, M; Machin, S; (2011) Guidelines for the laboratory investigation of heritable disorders of platelet function. BRIT J HAEMATOL , 155 (1) 30 - 44. 10.1111/j.1365-2141.2011.08793.x.

Hart, DP; Skelton, S; Moss, DS; Sansom, CE; Gomez, K; Shepherd, AJ; (2011) Use of artificial neural networks for large scale prediction of factor VIII derived CD4 T cell epitopes. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 pp. 930-931.

Hartig, N; Munoz-Alegre, M; Young, L; Rodriguez-Viciana, P; (2011) Role of R-Ras GTPases in the Wnt-Planar Cell Polarity pathway. In: (Proceedings) Annual Meeting of the American-Society-for-Cell-Biology (ASCB). AMER SOC CELL BIOLOGY

Hartley, JA; (2011) The development of pyrrolobenzodiazepines as antitumour agents. EXPERT OPIN INV DRUG , 20 (6) 733 - 744. 10.1517/13543784.2011.573477.

Hartley, JM; Spanswick, VJ; Hartley, JA; (2011) Measurement of DNA damage in individual cells using the Single Cell Gel Electrophoresis (Comet) assay. Methods Mol Biol , 731 pp. 309-320. 10.1007/978-1-61779-080-5_25.

Hartmann, S; Agostinelli, C; Klapper, W; Korkolopoulou, P; Koch, K; Marafioti, T; Piccaluga, PP; (2011) Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays? HISTOPATHOLOGY , 59 (6) pp. 1173-1182. 10.1111/j.1365-2559.2011.04069.x.

Hayee, B; Antonopoulos, A; Murphy, EJ; Rahman, FZ; Sewell, G; Smith, BN; McCartney, S; (2011) G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction. GLYCOBIOLOGY , 21 (7) 914 - 924. 10.1093/glycob/cwr023.

Haylock-Jacobs, S; Comerford, I; Bunting, M; Kara, E; Townley, S; Klingler-Hoffmann, M; Vanhaesebroeck, B; (2011) PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J Autoimmun , 36 (3-4) pp. 278-287. 10.1016/j.jaut.2011.02.006.

Hergovich, A; (2011) MOB control: Reviewing a conserved family of kinase regulators. CELL SIGNAL , 23 (9) 1433 - 1440. 10.1016/j.cellsig.2011.04.007.

Herzog, B; Pellet-Many, C; Britton, G; Hartzoulakis, B; Zachary, IC; (2011) VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Molecular Biology of the Cell , 22 (15) 2766 - 2776. 10.1091/mbc.E09-12-1061. Green open access
file

Herzog, RW; Davidoff, AM; Markusic, DM; Nathwani, AC; (2011) AAV Vector Biology in Primates: Finding the Missing Link? MOL THER , 19 (11) 1923 - 1924. 10.1038/mt.2011.218.

Hillmen, P; Gribben, JG; Follows, GA; Milligan, D; Sayala, HA; Moreton, P; Oscier, DG; (2011) RITUXIMAB PLUS CHLORAMBUCIL (R-CHLORAMBUCIL) AS FIRST-LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): FINAL ANALYSIS OF AN OPEN-LABEL PHASE II STUDY. In: ANNALS OF ONCOLOGY. (pp. 123 - 123). OXFORD UNIV PRESS

Hillmen, P; Gribben, JG; Follows, GA; Milligan, D; Sayala, HA; Moreton, P; Oscier, DG; (2011) Final response assessment of the CLL208 trial: an open-label phase II study to investigate the safety and efficacy of rituximab plus chlorambucil in previously untreated patients with CD20-positive B-cell chronic lymphocytic leukaemia (CLL). In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 21). WILEY-BLACKWELL

Hiwarkar, P; Shaw, BE; Tredger, JM; Brown, NW; Kulkarni, S; Saso, R; Evans, S; (2011) Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin. CLIN TRANSPLANT , 25 (2) 222 - 227. 10.1111/j.1399-0012.2010.01226.x.

Hochdörfer, T; Kuhny, M; Zorn, CN; Hendriks, RW; Vanhaesebroeck, B; Bohnacker, T; Krystal, G; (2011) Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cells. Cell Signal , 23 (5) pp. 866-875. 10.1016/j.cellsig.2011.01.012.

Hollenbach, JA; Mack, SJ; Gourraud, P-A; Single, RM; Maiers, M; Middleton, D; Thomson, G; (2011) A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. TISSUE ANTIGENS , 78 (5) pp. 333-344. 10.1111/j.1399-0039.2011.01777.x.

Holme, H; Nanduri, V; (2011) Superior vena cava obstruction: dangers of a missed diagnosis. J Paediatr Child Health , 47 (3) pp. 150-151. 10.1111/j.1440-1754.2010.01741.x.

Hoorn, EJ; Walsh, SB; McCormick, JA; Furstenberg, A; Yang, CL; Roeschel, T; Paliege, A; (2011) The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. NAT MED , 17 (10) 1304 - U339. 10.1038/nm.2497.

Howie, AJ; (2011) Problems with 'focal segmental glomerulosclerosis'. Pediatr Nephrol , 26 (8) pp. 1197-1205. 10.1007/s00467-010-1701-0.

Hughes, D; (2011) Gaucher disease: hematologic and oncologic implications. Clin Adv Hematol Oncol , 9 (10) pp. 771-772.

Hughes, D; Barba-Romero, MA; Hollak, CE; Giugliani, R; Deegan, PB; (2011) DELAYED MENARCHE AND EARLY MENOPAUSE IN FEMALES WITH FABRY DISEASE. JOURNAL OF INHERITED METABOLIC DISEASE , 34 S186-S186.

Hughes, DA; Al-Sayed, M; Belmatoug, N; Bodamer, O; Bottcher, T; Cappellini, M; Cohen, IJ; (2011) Early access experience with VPRIV (R): Recommendations for 'core data' collection. BLOOD CELL MOL DIS , 47 (2) 140 - 142. 10.1016/j.bcmd.2010.10.015.

Hughes, DA; Romero, MAB; Hollak, CEM; Giugliani, R; Deegan, PB; FOS Investigators, ; (2011) Response of women with Fabry disease to enzyme replacement therapy: Comparison with men, using data from FOS-the Fabry Outcome Survey. MOL GENET METAB , 103 (3) 207 - 214. 10.1016/j.ymgme.2011.03.022.

I

Ibrahim, AR; Eliasson, L; Apperley, JF; Milojkovic, D; Bua, M; Szydlo, R; Mahon, F-X; (2011) Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. BLOOD , 117 (14) pp. 3733-3736. 10.1182/blood-2010-10-309807.

Ibrahim, M; Dodson, A; O'Grady, T; Parry, S; Miller, K; Doolan, C; Jasani, B; (2011) HER2 ICC Web-based interpretive scheme: a pilot study by the UK National External Quality Assessment Scheme for Immunocytochemistry and In Situ Hybridisation (UK NEQAS ICC & ISH). VIRCHOWS ARCH , 459 S73 - S74.

Ibrahim, M; Herriott, K; Parry, S; Miller, K; (2011) Audit of breast biomarkers markers, HER2.ER & PR in the UK: an update by the UK National External Quality Assessment Scheme for Immunocytochemistry and In Situ Hybridisation (UK NEQAS ICC & ISH). VIRCHOWS ARCH , 459 S74 - S74.

Ibrahim, M; Parry, S; Miller, K; (2011) Immunocytochemical staining of breast biomarkers HER2, ER and PR; potential pitfalls of false positive/negative staining: findings of the UK NEQAS ICC & ISH. VIRCHOWS ARCH , 459 S74 - S74.

Iorio, M; Piovan, C; Di Leva, G; Palmieri, D; Casalini, P; Braccioli, L; Tortoreto, M; (2011) Breast cancer and microRNAs: Therapeutic impact. BREAST , 20 S6 - S6.

Isgro, G; Andreana, L; Garcovich, M; Luong, TV; Hall, A; Manousou, P; Goossens, N; (2011) COLLAGEN PROPORTIONATE AREA: BEST INDEX TO PREDICT DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS OF DIFFERENT ETIOLOGIES. In: (Proceedings) 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). (pp. S69-S70). ELSEVIER SCIENCE BV

Isgro, G; Hall, AR; Andreana, L; Luong, T; Burroughs, AK; Dhillon, AP; (2011) EDITED AND NON-EDITED COLLAGEN PROPORTIONATE AREA: PREDICTION OF DECOMPENSATION IN CIRRHOSIS. In: HEPATOLOGY. (pp. 1276A - 1276A). WILEY-BLACKWELL

J

JD, O; Adcock, DM; Ambrose Bush, T; de Moerloose, P; Gardiner, C; Ginyard, M; McMahan, CA; (2011) Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline H59-A. Clinical and Laboratory Standards Institute

Jamal-Hanjani, M; Pettengell, R; (2011) Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma. Expert Opin Drug Metab Toxicol , 7 (11) pp. 1441-1448. 10.1517/17425255.2011.618834.

Jennings, BH; (2011) Drosophila - a versatile model in biology & medicine. MATER TODAY , 14 (5) 190 - 195. Gold open access

Jiao, Y; Lawler, K; Patel, GS; Purushotham, A; Jones, AF; Grigoriadis, A; Tutt, A; (2011) DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference. BMC BIOINFORMATICS , 12 (ARTN 403) 10.1186/1471-2105-12-403. Gold open access

Johansson, AM; Hill, N; Perisoglou, M; Whelan, J; Karlsson, MO; Standing, JF; (2011) A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma. Therapeutic Drug Monitoring , 33 (6) pp. 711-718. 10.1097/FTD.0b013e31823615e1.

Johansson, ÅM; Hill, N; Perisoglou, M; Whelan, J; Karlsson, MO; Standing, JF; (2011) A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma. Ther Drug Monit , 33 (6) pp. 711-718. 10.1097/FTD.0b013e31823615e1.

Juergens, H; Daw, NC; Geoerger, B; Ferrari, S; Villarroel, M; Aerts, I; Whelan, J; (2011) Preliminary Efficacy of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma. JOURNAL OF CLINICAL ONCOLOGY , 29 (34) pp. 4534-4540. 10.1200/JCO.2010.33.0670.

K

Kallinikou, K; Anjos-Afonso, F; Blundell, MP; Ings, SJ; Kassen, D; Thrasher, AJ; Linch, DC; (2011) CD26 Inhibition Can Aid the Homing of Cytokine Activated Mobilized Peripheral Blood (MPB)CD34+Cells to the Bone Marrow (BM) but a Ligand Dependent Attachment Defect Prevents Their Long Term Retention and Subsequent Engraftment. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 68). AMER SOC HEMATOLOGY

Kanga, U; McWhinnie, A; Mourya, MK; Sharma, R; Shaw, BE; Madrigal, A; Mehra, NK; (2011) HLA-DPB1 POLYMORPHISM IN NORTH INDIAN POPULATION. In: (Proceedings) 37th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. S137-S137). ELSEVIER SCIENCE INC

Kanga, U; McWhinnie, AJ; Mourya, M; Shaw, BE; Madrigal, JA; Mehra, NK; (2011) A novel HLA-DPB1 allele, DPB1*125:01, identified by sequence-based typing in an Indian individual. TISSUE ANTIGENS , 77 (1) 85 - 87. 10.1111/j.1399-0039.2010.01562.x.

Kapoor, RR; Flanagan, SE; James, CT; McKiernan, J; Thomas, AM; Harmer, SC; Shield, JP; (2011) Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations. Diabetologia , 54 (10) pp. 2575-2583. 10.1007/s00125-011-2207-4. Green open access
file

Karwacz, K; Bricogne, C; MacDonald, D; Arce, F; Bennett, CL; Collins, M; Escors, D; (2011) PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8(+) T cells. EMBO Molecular Medicine , 3 (10) 581 - 592. 10.1002/emmm.201100165. Green open access
file

Kasperavičiute, D; Catarino, CB; Chinthapalli, K; Clayton, LMS; Thom, M; Martinian, L; Cohen, H; (2011) Uncovering genomic causes of co-morbidity in epilepsy: Gene-driven phenotypic characterization of rare microdeletions. PLoS ONE , 6 (8) , Article e23182. 10.1371/journal.pone.0023182. Green open access
file

Kassen, D; Rabin, N; Lath, D; Croucher, P; Yong, K; (2011) Deregulation of the bone marrow stromal compartment occurs early in multiple myeloma and precedes osteolytic bone disease. In: BONE. (pp. S253 - S254). ELSEVIER SCIENCE INC

Kassen, D; Rabin, N; Lath, D; Croucher, PI; Yong, K; (2011) Mechanisms of osteoblast supression in multiple myeolma. In: BONE. (pp. S37 - S37). ELSEVIER SCIENCE INC

Kato, H; Seto, K; Kobayashi, N; Yoshinaga, K; Meyer, T; Takei, M; (2011) CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. LIFE SCI , 89 (17-18) 603 - 608. 10.1016/j.lfs.2011.07.019.

Katodritou, E; Terpos, E; North, J; Kottaridis, P; Verrou, E; Gastari, V; Chadjiaggelidou, C; (2011) Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells. AMERICAN JOURNAL OF HEMATOLOGY , 86 (12) pp. 967-973. 10.1002/ajh.22163.

Kautz-Neu, K; Noordegraaf, M; Dinges, S; Bennett, CL; John, D; Clausen, BE; von Stebut, E; (2011) Langerhans cells are negative regulators of the anti-leishmania response. Journal of Experimental Medicine , 208 (5) pp. 885-91. 10.1084/jem.20102318.

Keane, TM; Goodstadt, L; Danecek, P; White, MA; Wong, K; Yalcin, B; Heger, A; (2011) Mouse genomic variation and its effect on phenotypes and gene regulation. Nature , 477 (7364) pp. 289-294. 10.1038/nature10413.

Kepp, O; Galluzzi, L; Martins, I; Schlemmer, F; Adjemian, S; Michaud, M; Sukkurwala, AQ; (2011) Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev , 30 (1) pp. 61-69. 10.1007/s10555-011-9273-4.

Khan, AB; Lipman, M; Hopkins, S; Marshall, N; Galloway, M; Kibbler, C; (2011) Poor outcome of central nervous system invasive aspergillosis in HIV infection despite galactomannan-based diagnosis: A case series and literature review. Infectious Diseases in Clinical Practice , 19 (4) pp. 299-302. 10.1097/IPC.0b013e3182041769.

Khan, MS; El-Khouly, F; Davies, P; Toumpanakis, C; Caplin, ME; (2011) Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel). ALIMENTARY PHARMACOLOGY & THERAPEUTICS , 34 (2) pp. 235-242. 10.1111/j.1365-2036.2011.04693.x.

Khan, MS; El-Khouly, F; Quigley, AM; Caplin, M; Toumpanakis, C; (2011) Y90-DOTATATE in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Survival following Different Indications for Treatment. In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; El-Khouly, F; Toumpanakis, C; Meyer, T; Caplin, M; Luong, T; (2011) Ki-67 is a Better Prognostic Marker than Mitotic Count in Neuroendocrine Tumors. In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; Tsigani, T; Garcia-Hernandez, J; Caplin, M; Meyer, T; (2011) Circulating Tumor Cells (CTCs) Correlate with Overall Survival in Neuroendocrine Tumors (NETs). In: (Proceedings) 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease. (pp. p. 31). KARGER

Khan, MS; Tsigani, T; Rashid, M; Rabouhans, JS; Yu, D; Tu, VL; Caplin, M; (2011) Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors. CLIN CANCER RES , 17 (2) 337 - 345. 10.1158/1078-0432.CCR-10-1776.

Khwaja, A; (2011) PI3K as a Target for Therapy in Haematological Malignancies. CURR TOP MICROBIOL , 347 169 - 188. 10.1007/82_2010_71.

Khwaja, A; Quinn, J; Yong, KL; (2011) The myeloma bone marrow environment and survival signaling. In: Myeloma: Pathology, Diagnosis, and Treatment. (pp. 64-83).

Kimata, Y; Kitamura, K; Fenner, N; Yamano, H; (2011) Mes1 controls the meiosis I to meiosis II transition by distinctly regulating the anaphase-promoting complex/cyclosome coactivators Fzr1/Mfr1 and Slp1 in fission yeast. MOL BIOL CELL , 22 (9) 1486 - 1494. 10.1091/mbc.E10-09-0774. Gold open access

King, RJ; Confer, DL; Greinix, HT; Halter, J; Horowitz, M; Schmidt, AH; Costeas, P; (2011) Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplant , 46 (1) pp. 10-13. 10.1038/bmt.2010.37.

Kistler, AD; Siwy, J; Breunig, F; Jeevaratnam, P; Scherl, A; Mullen, W; Warnock, DG; (2011) A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy. PLOS ONE , 6 (6) , Article e20534. 10.1371/journal.pone.0020534. Green open access
file

Knowles, S; Cohen, H; (2011) The 2010 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Kocjan, G; Chandra, A; Cross, PA; Giles, T; Johnson, SJ; Stephenson, TJ; Roughton, M; (2011) The Interobserver Reproducibility of Thyroid Fine-Needle Aspiration Using the UK Royal College of Pathologists' Classification System. AM J CLIN PATHOL , 135 (6) 852 - 859. 10.1309/AJCPZ33MVMGZKEWU.

Kothari, J; Ljubic, A; Peggs, KS; Thomson, K; Morris, E; Virchis, AE; Lambert, J; (2011) Autologous Stem Cell Transplantation Using BEAM Conditioning Is Highly Effective in Patients with Follicular Lymphoma Regardless of Prior Rituximab Exposure. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 886). AMER SOC HEMATOLOGY

Kottaridis, P; Tsirogianni, M; North, J; Marden, C; Mackinnon, S; Lowdell, MW; (2011) Results of a Phase 1 Clinical Trial of Allogeneic Tumor-Primed Natural Killer Cells in AML. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). (pp. p. 431). AMER SOC HEMATOLOGY

Kristeleit, RS; baird, R; venugopal, B; wilkins, D; maccormick, F; granata, R; crawford, D; (2011) Cardiac effects in a first-in-human (FIH), pharmacokinetic (PK), pharmacodynamic (PD) phase I trial of JNJ-26481585, a second-generation oral hydroxamate histone deacetylase inhibitor (HDACi), in patients with refractory cancer. Molecular Cancer Therapeutics , 10 (11)

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; Carey, MS; (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY , 29 (18)

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; Carey, MS; (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; Carey, MS; (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. J Clin Oncol , 29 (18_suppl) LBA5006-.

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; Carey, MS; (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. J Clin Oncol , 29 (15_suppl) LBA5006-.

Kroemer, G; Adjemian, S; Michaud, M; Martins, I; Kepp, O; Sukkurwala, AQ; Menger, L; (2011) [Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy]. Bull Mem Acad R Med Belg , 166 (3-4) pp. 130-138.

Krug, LM; Kindler, H; Calvert, H; Manegold, C; Tsao, AS; Fennell, D; Lubiniecki, GM; (2011) VANTAGE 014: Vorinostat (V) in Patients With Advanced Malignant Pleural Mesothelioma (MPM) who Have Failed Prior Pemetrexed and Either Cisplatin or Carboplatin Therapy: A Phase iii, Randomized, Double-Blind, Placebo-Controlled Trial. EUROPEAN JOURNAL OF CANCER , 47 pp. 2-3.

Kudsiova, L; Fridrich, B; Ho, J; Mustapa, MFM; Campbell, F; Welser, K; Keppler, M; (2011) Lipopolyplex Ternary Delivery Systems Incorporating C14 Glycerol-Based Lipids. MOL PHARMACEUT , 8 (5) 1831 - 1847. 10.1021/mp2001796.

Kudsiova, L; Ho, J; Fridrich, B; Harvey, R; Keppler, M; Ng, T; Hart, SL; (2011) Lipid chain geometry of C14 glycerol-based lipids: effect on lipoplex structure and transfection. MOL BIOSYST , 7 (2) 422 - 436. 10.1039/c0mb00149j.

Kulkarni, S; Sitaru, C; Jakus, Z; Anderson, KE; Damoulakis, G; Davidson, K; Hirose, M; (2011) PI3Kβ plays a critical role in neutrophil activation by immune complexes. Sci Signal , 4 (168) ra23-. 10.1126/scisignal.2001617.

Kumar, MS; Swanton, C; (2011) KRAS 3'-UTR variants and stratification of breast-cancer risk. Lancet Oncol , 12 (4) pp. 318-319. 10.1016/S1470-2045(11)70065-1.

Kuter, DJ; Mehta, A; Hollak, C; Giraldo, P; Hughes, D; Belmatoug, N; Brand, M; (2011) Miglustat Therapy in Type 1 Gaucher Disease: Long-Term Treatment Experience From a Multicenter, Retrospective Cohort Study. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1385). AMER SOC HEMATOLOGY

L

Lafont, E; Kitatani, K; Okazaki, T; Ségui, B; (2011) Regulation of death and growth signals at the plasma membrane by sphingomyelin synthesis: implications for hematological malignancies. Recent Pat Anticancer Drug Discov , 6 (3) pp. 324-333.

Lambrianides, A; Turner-Stokes, T; Pericleous, C; Ehsanullah, J; Papadimitraki, E; Poulton, K; Ioannou, Y; (2011) Interactions of Human Monoclonal and Polyclonal Antiphospholipid Antibodies With Serine Proteases Involved in Hemostasis. ARTHRITIS AND RHEUMATISM , 63 (11) pp. 3512-3521. 10.1002/art.30525.

Larkin, J; Swanton, C; Pickering, L; (2011) Optimizing treatment of metastatic renal cell carcinoma by changing mechanism of action. Expert Rev Anticancer Ther , 11 (4) pp. 639-649. 10.1586/era.11.21.

Lawley, S; Cohen, H; Pavord, S; Fitzmaurice, D; (2011) Dragons den on oral anticoagulants for atrial fibrillation. Presented at: British society for haematology annual scientific meeting, Brighton.

Lawrenson, K; Sproul, D; Grun, B; Notaridou, M; Benjamin, E; Jacobs, IJ; Dafou, D; (2011) Modelling genetic and clinical heterogeneity in epithelial ovarian cancers. CARCINOGENESIS , 32 (10) pp. 1540-1549. 10.1093/carcin/bgr140.

Lawrie, AS; Canciani, MT; Iseppi, J; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) High throughput detection of von Willebrand's disease using a new coagulation analyser. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 p. 672.

Lawrie, AS; Mackie, IJ; Machin, SJ; Peyvandi, F; (2011) Evaluation of an automated platelet-based assay of ristocetin cofactor activity. HAEMOPHILIA , 17 (2) 252 - 256. 10.1111/j.1365-2516.2010.02419.x.

Lawson, ARJ; Hindley, GFL; Forshew, T; Tatevossian, RG; Jamie, GA; Kelly, GP; Neale, GA; (2011) RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology. Genome Res , 21 (4) pp. 505-514. 10.1101/gr.115782.110.

Ledermann, JA; (2011) Benefits of Enhancing the Platinum-Free Interval in the Treatment of Relapsed Ovarian Cancer More Than Just a Hypothesis? INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 21 S9 - S11. 10.1097/IGC.0b013e318217b30b.

Ledermann, JA; Hackshaw, A; Kaye, S; Jayson, G; Gabra, H; McNeish, I; Earl, H; (2011) Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer. J CLIN ONCOL , 29 (28) 3798 - 3804. 10.1200/JCO.2010.33.5208.

Ledermann, JA; Harter, P; Gourley, C; Friedlander, M; Vergote, IB; Rustin, GJ; Scott, C; (2011) Phase II randomized placebo-controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC). J Clin Oncol , 29 (15_suppl) 5003-.

Ledermann, JA; Harter, P; Gourley, C; Friedlander, M; Vergote, IB; Rustin, GJS; Scott, C; (2011) Phase II randomized placebo-controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC). JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

Ledermann, JA; Marth, C; Carey, MS; Birrer, M; Bowtell, DDL; Kaye, S; McNeish, I; (2011) Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer. INT J GYNECOL CANCER , 21 (4) 763 - 770. 10.1097/IGC.0b013e31821b2669.

Ledermann, JA; Raja, FA; (2011) Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer. EUROPEAN JOURNAL OF CANCER , 47 S104-S115.

Ledermann, JA; Raja, FA; (2011) Mucinous cancers: Ovary. pp. 67-73. 10.1007/978-3-642-13492-0_5.

Lee, AJX; Endesfelder, D; Rowan, AJ; Walther, A; Birkbak, NJ; Futreal, PA; Downward, J; (2011) Chromosomal instability confers intrinsic multidrug resistance. Cancer Res , 71 (5) pp. 1858-1870. 10.1158/0008-5472.CAN-10-3604.

Lee, JW; Yoon, S-S; Shen, ZX; Ganser, A; Hsu, H-C; El-Ali, A; Habr, D; (2011) Hematologic Responses in Patients with Aplastic Anemia Treated with Deferasirox: A Post-Hoc Analysis From the EPIC Study. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. pp. 591-592). AMER SOC HEMATOLOGY

Lemech, C; Arkenau, HT; (2011) Biomarkers in advanced colorectal cancer: Challenges in translating clinical research into practice. Cancers , 3 (2) pp. 1844-1860. 10.3390/cancers3021844. Gold open access

Lemech, CR; Kristeleit, RS; Arkenau, H; (2011) Novel Oncology drug development strategies in the era of personalised medicine. In: Drug Discovery and Development. InTech

Lemech, CR; Kristeleit, RS; Arkenau, HT; (2011) Novel Oncology Drug Development Strategies in the Era of Personalised Medicine. In: Kapetanovic, IM, (ed.) Drug Discovery and Development - Present and Future.

Leoni, LM; Hartley, JA; (2011) Mechanism of Action: The Unique Pattern of Bendamustine-Induced Cytotoxicity. SEMIN HEMATOL , 48 (2) S12 - S23. 10.1053/j.seminhematol.2011.03.003.

Li, Q; Birkbak, NJ; Gyorffy, B; Szallasi, Z; Eklund, AC; (2011) Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics , 12 474-. 10.1186/1471-2105-12-474.

Li, Q; Eklund, AC; Birkbak, NJ; Desmedt, C; Haibe-Kains, B; Sotiriou, C; Symmans, WF; (2011) Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response. BMC Bioinformatics , 12 310-. 10.1186/1471-2105-12-310.

Li, S-C; Chan, W-C; Lai, C-H; Tsai, K-W; Hsu, C-N; Jou, Y-S; Chen, H-C; (2011) UMARS: Un-MAppable Reads Solution. BMC Bioinformatics , 12 (Suppl 1) S9-S9. 10.1186/1471-2105-12-S1-S9. Gold open access

Li, S-C; Liao, Y-L; Chan, W-C; Ho, M-R; Tsai, K-W; Hu, L-Y; Lai, C-H; (2011) Interrogation of rabbit miRNAs and their isomiRs. Genomics , 98 (6) pp. 453-459. 10.1016/j.ygeno.2011.08.008.

Liccardi, G; Hartley, JA; Hochhauser, D; (2011) EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment. CANCER RES , 71 (3) 1103 - 1114. 10.1158/0008-5472.CAN-10-2384. Gold open access

Lin, S; Kiakos, K; Lee, M; Hochhauser, D; Hartley, JA; (2011) Targeting the Mlul cell cycle box (MCB) sequence 5 '-ACGCGT-3 ' in the human Dbf4 promoter using the rationally designed polyamide formamido-imidazole-pyrrole-imidazole (f-IPI). CANCER RESEARCH , 71 10.1158/1538-7445.AM2011-665.

Lindblad-Toh, K; Garber, M; Zuk, O; Lin, MF; Parker, BJ; Washietl, S; Kheradpour, P; (2011) A high-resolution map of human evolutionary constraint using 29 mammals. NATURE , 478 (7370) pp. 476-482. 10.1038/nature10530.

Linthorst, GE; Germain, DP; Hollak, CEM; Hughes, D; Rolfs, A; Wanner, C; Mehta, A; (2011) Expert opinion on temporary treatment recommendations for Fabry the disease during the shortage of enzyme replacement therapy (ERT). MOL GENET METAB , 102 (1) 99 - 102. 10.1016/j.ymgme.2010.11.155.

Liu, H; Wang, W; Chew, S-K; Lee, S-C; Li, J; Vassiliou, GS; Green, T; (2011) Stella-Cre mice are highly efficient Cre deleters. Genesis , 49 (8) pp. 689-695. 10.1002/dvg.20741.

Lobo, C; McQueen, A; Beale, T; Kocjan, G; (2011) The UK Royal College of Pathologists Thyroid Fine-Needle Aspiration Diagnostic Classification Is a Robust Tool for the Clinical Management of Abnormal Thyroid Nodules. ACTA CYTOLOGICA , 55 (6) pp. 499-506. 10.1159/000333234.

Locke, DP; Hillier, LW; Warren, WC; Worley, KC; Nazareth, LV; Muzny, DM; Yang, S-P; (2011) Comparative and demographic analysis of orang-utan genomes. Nature , 469 (7331) pp. 529-533. 10.1038/nature09687.

Lolkema, MP; Arkenau, H-T; Harrington, K; Roxburgh, P; Morrison, R; Roulstone, V; Twigger, K; (2011) A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clin Cancer Res , 17 (3) pp. 581-588. 10.1158/1078-0432.CCR-10-2159.

Lopez, MN; Pesce, B; Kurte, M; Perez, C; Segal, G; Roa, J; Aguillon, JC; (2011) A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGF-beta plus tolerogenic dendritic cells. IMMUNOBIOLOGY , 216 (10) 1117 - 1126. 10.1016/j.imbio.2011.04.006.

Lotta, LA; Wu, HM; Mackie, IJ; Noris, M; Veyradier, A; Machin, SJ; Remuzzi, G; (2011) Residual plasmatic activity of ADAMTS13 in congenital thrombotic thrombocytopenic purpura and its correlation with disease phenotype. J THROMB HAEMOST , 9 26 - 27.

Lotta, LA; Wu, HM; Scully, MA; Noris, M; Veyradier, A; Mackie, IJ; Remuzzi, G; (2011) Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 966). AMER SOC HEMATOLOGY

Louis, CU; Savoldo, B; Dotti, G; Pule, M; Yvon, E; Myers, GD; Rossig, C; (2011) Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood , 118 (23) pp. 6050-6056. 10.1182/blood-2011-05-354449.

Lowry, L; Smith, P; Qian, W; Falk, S; Benstead, K; Illidge, T; Linch, D; (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol , 100 (1) pp. 86-92. 10.1016/j.radonc.2011.05.013.

Luc, S; Macaulay, IC; Buza-Vidas, N; Bouriez-Jones, T; Lutteropp, M; Woll, P; Mead, AJ; (2011) The Earliest Thymic T Cell Progenitors Sustain B Cell and Myeloid Lineage Potentials. In: (Proceedings) 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. (pp. p. 1011). AMER SOC HEMATOLOGY

Luevano, ME; Pedroza-Pacheco, I; Derniame, S; Escobedo-Cousin, MH; Madrigal, JA; Saudemont, A; (2011) Generation of natural killer cells from cord blood stem cells, characterization and application for immunotherapy. In: (Proceedings) Annual Congress of the British-Society-for-Immunology. (pp. p. 187). WILEY-BLACKWELL

M

Ma, GL; Dhillon, AP; Hall, AR; Burroughs, AK; Tsochatzis, E; Burgess, G; Guo, F; (2011) ISHAK STAGE PROGRESSION RATE MODELING FOR POST LIVER TRANSPLANT (POLT) PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION. In: HEPATOLOGY. (pp. 579A - 579A). WILEY-BLACKWELL

MacGregor, A; Frith, A; Hackshaw, A; (2011) Migraine and co-morbid depression: an open label study of eletriptan and sertraline. Journal of Clinical Psychopharmacology , 31 (3) pp. 392-393. (In press).

Mackie, I; Eapen, CE; Neil, D; Lawrie, AS; Chitolie, A; Shaw, JC; Elias, E; (2011) Idiopathic Noncirrhotic Intrahepatic Portal Hypertension is Associated with Sustained ADAMTS13 Deficiency. DIGEST DIS SCI , 56 (8) 2456 - 2465. 10.1007/s10620-011-1729-4.

Mackie, IJ; Chitolie, A; Westwood, JP; Lawrie, A; Carr, P; Liesner, R; Cohen, H; (2011) Antibodies against prothrombin/phosphatidyl serine in thrombosis an pregnancy morbidity. In: (Proceedings) VII European Forum on antiphospholipid antibodies.

Mackie, IJ; Langley, K; Chitolie, A; Leisner, R; Scully, M; Machin, S; Peyvandi, F; (2011) Discrepancies between different types of ADAMTS13 assays in patients with thrombotic microangiopathies. J THROMB HAEMOST , 9 210 - 210.

Mackinnon, S; Chakraverty, R; (2011) Families get mobilized to treat AML. BLOOD , 117 (3) 746 - 748. 10.1182/blood-2010-11-315929.

Maggio, A; Filosa, A; Vitrano, A; Aloj, G; Kattamis, A; Ceci, A; Fucharoen, S; (2011) Iron chelation therapy in thalassemia major: A systematic review with meta-analyses of 1520 patients included on randomized clinical trials. BLOOD CELLS MOLECULES AND DISEASES , 47 (3) pp. 166-175. 10.1016/j.bcmd.2011.07.002.

Mahadevan, D; Plummer, R; Squires, MS; Rensvold, D; Kurtin, S; Pretzinger, C; Dragovich, T; (2011) A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors. ANN ONCOL , 22 (9) 2137 - 2143. 10.1093/annonc/mdq734.

Manchanda, R; Abdelraheim, A; Johnson, M; Rosenthal, AN; Benjamin, E; Brunell, C; Burnell, M; (2011) Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG-INT J OBSTET GY , 118 (7) 814 - 824. 10.1111/j.1471-0528.2011.02920.x.

Mandeville, H.C.; (2011) Exploration of the clinical interaction between vascular targeting agents and radiotherapy. Doctoral thesis, UCL (University College London). Green open access
file

Manousou, P; Dhillon, AP; Isgro, G; Calvaruso, V; Luong, TV; Tsochatzis, E; Xirouchakis, E; (2011) Digital Image Analysis of Liver Collagen Predicts Clinical Outcome of Recurrent Hepatitis C Virus 1 Year After Liver Transplantation. LIVER TRANSPLANT , 17 (2) 178 - 188. 10.1002/lt.22209.

Manousou, P; Kalambokis, G; Grillo, F; Watkins, J; Xirouchakis, E; Pleguezuelo, M; Leandro, G; (2011) Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. LIVER INT , 31 (5) 730 - 739. 10.1111/j.1478-3231.2011.02488.x.

Mansour, MR; Look, AT; (2011) Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma. CANCER CELL , 20 (5) pp. 559-561. 10.1016/j.ccr.2011.10.027.

Mansur, A; Little, MA; Oh, WC; Jacques, S; Nightingale, P; Howie, AJ; Savage, COS; (2011) Immune Profile and Epstein-Barr Virus Infection in Acute Interstitial Nephritis: An Immunohistochemical Study in 78 Patients. NEPHRON CLINICAL PRACTICE , 119 (4) C293-C300. 10.1159/000329671.

Maramba, A; North, J; Lowdell, MW; Donaldson, C; (2011) IgM ligation triggers Zeta associated protein of 70 kDa (ZAP-70) tyrosine 292 and 319 phosphorylation in B-Chronic lymphocytic leukaemia (B-CLL). In: (Proceedings) 51st Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 72-73). WILEY-BLACKWELL

Marks, R; Rizzi, M; Neumann, C; Fielding, A; Goldacker, S; Salzer, U; Eibel, H; (2011) Allogeneic stem cell transplantation in patients with common variable immunodeficiency. In: BONE MARROW TRANSPLANTATION. (pp. S163 - S163). NATURE PUBLISHING GROUP

Marsh, D; Suchak, K; Moutasim, KA; Vallath, S; Hopper, C; Jerjes, W; Upile, T; (2011) Stromal features are predictive of disease mortality in oral cancer patients. J PATHOL , 223 (4) 470 - 481. 10.1002/path.2830.

Marsh, D.J.; (2011) The αvβ6 Integrin in cancer. Doctoral thesis, UCL (University College London). Green open access
file

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update April 2011. TISSUE ANTIGENS , 78 (4) pp. 299-306. 10.1111/j.1399-0039.2011.01758.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update August 2010. TISSUE ANTIGENS , 77 (2) pp. 167-175. 10.1111/j.1399-0039.2010.01595.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update August 2011. TISSUE ANTIGENS , 78 (6) pp. 474-481. 10.1111/j.1399-0039.2011.01792.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update December 2010. TISSUE ANTIGENS , 77 (4) pp. 362-363. 10.1111/j.1399-0039.2011.01642.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update February 2011. TISSUE ANTIGENS , 77 (6) pp. 613-617. 10.1111/j.1399-0039.2011.01688.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update January 2011. TISSUE ANTIGENS , 77 (6) pp. 603-612. 10.1111/j.1399-0039.2011.01687.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2010. TISSUE ANTIGENS , 77 (2) pp. 162-166. 10.1111/j.1399-0039.2010.01594.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update July 2011. TISSUE ANTIGENS , 78 (6) pp. 468-473. 10.1111/j.1399-0039.2011.01790.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update June 2011. TISSUE ANTIGENS , 78 (4) pp. 314-319. 10.1111/j.1399-0039.2011.01760.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update March 2011. TISSUE ANTIGENS , 78 (1) pp. 77-79. 10.1111/j.1399-0039.2011.01696.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update May 2011. TISSUE ANTIGENS , 78 (4) pp. 307-313. 10.1111/j.1399-0039.2011.01759.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update November 2010. TISSUE ANTIGENS , 77 (4) pp. 355-361. 10.1111/j.1399-0039.2011.01643.x.

Marsh, SGE; (2011) Nomenclature for factors of the HLA system, update October 2010. TISSUE ANTIGENS , 77 (4) pp. 349-354. 10.1111/j.1399-0039.2011.01644.x.